Artwork
iconShare
 
Manage episode 491791741 series 2464201
Content provided by Psychopharmacology Institute. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Psychopharmacology Institute or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

In this episode, we explore groundbreaking head-to-head research comparing topiramate and naltrexone for alcohol use disorder, revealing surprising equivalence in effectiveness. Could the off-label option actually be as good as our FDA-approved standard for treating problematic drinking?

Faculty: David Gorelick, M.D. Host: Richard Seeber, M.D.

  continue reading

109 episodes